[artículo] 
inThe Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.1 (Enero) . - pp.62–68

Título :	Escitalopram treatment for depressive disorder following acute coronary syndrome : A 24-week double-blind, placebo-controlled trial
Tipo de documento:	texto impreso
Autores:	Jae-Min Kim, Autor ; Kyung-Yeol Bae, Autor ; Robert Stewart, Autor
Fecha de publicación:	2020
Artículo en la página:	pp.62–68
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Síndrome coronario agudo, Citalopram, Trastorno depresivo, Inhibidores de la captación de serotonina.
Resumen:	Depression is common after acute coronary syndrome (ACS) and has adverse effects on prognosis. There are few evidence-based interventions for treating depression in ACS. This study investigated the efficacy and safety of escitalopram in treating depressive disorders identified 2–14 weeks after a confirmed ACS episode.
Link:	./index.php?lvl=notice_display&id=21805

[artículo] Escitalopram treatment for depressive disorder following acute coronary syndrome : A 24-week double-blind, placebo-controlled trial [texto impreso] / Jae-Min Kim, Autor ; Kyung-Yeol Bae, Autor ; Robert Stewart, Autor . - 2020 . - pp.62–68.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2015 - Vol.76 - No.1 (Enero) . - pp.62–68

Palabras clave:	Síndrome coronario agudo, Citalopram, Trastorno depresivo, Inhibidores de la captación de serotonina.
Resumen:	Depression is common after acute coronary syndrome (ACS) and has adverse effects on prognosis. There are few evidence-based interventions for treating depression in ACS. This study investigated the efficacy and safety of escitalopram in treating depressive disorders identified 2–14 weeks after a confirmed ACS episode.
Link:	./index.php?lvl=notice_display&id=21805